INNOWAITA LAB Joins Forces with Swiss Lab–GENESENN to Advance Regenerative Medicine, Bringing Japanese Experts to Share Knowledge
INNOWAITA LAB Strengthens Collaboration with Swiss Lab and GENESENN, Inviting Japanese Experts to Share Knowledge and Explore the Future of Regenerative Medicine
INNOWAITA LAB has announced a significant collaboration with Swiss Lab and GENESENN at THE FUTURE OF REGENERATIVE MEDICINE, bringing together knowledge, expertise, and perspectives to explore and advance the future of Regenerative Medicine in Thailand.
The event was honored by the participation of Dr. Masaaki Nagayama, a specialist from Japan, who shared his knowledge, vision, and insights into the latest developments in Regenerative Medicine with physicians, healthcare professionals, business partners, and distinguished guests attending the event.
One of the key highlights of THE FUTURE OF REGENERATIVE MEDICINE was the participation of Dr. Masaaki Nagayama, a specialist from Japan, who delivered a presentation and exchanged perspectives with attendees. He presented concepts, knowledge, and emerging directions in Regenerative Medicine that are gaining international attention.
The event provided an important opportunity for Thailand’s healthcare sector to learn from the experience and perspectives of a Japanese specialist, while creating a platform for exchanging ideas on trends and the future role of Regenerative Medicine.
The collaboration between INNOWAITA LAB, Swiss Lab, and GENESENN reflects a shared vision to connect scientific knowledge, medical technologies, laboratory expertise, and professional networks from Thailand and abroad.
As an organization focused on delivering innovations that contribute to improving quality of life, INNOWAITA LAB places strong importance on building collaborations that can develop knowledge and further advance systematic approaches to healthcare. These efforts aim to prepare for changes in the medical and healthcare industry in the future.
Swiss Lab and GENESENN: Building a Connected Healthcare Ecosystem
The collaboration with Swiss Lab and GENESENN represents another important step for INNOWAITA LAB in building a healthcare ecosystem that connects expertise from diverse sectors.
Swiss Lab plays an important role in supporting knowledge and standards in laboratory services, while GENESENN is one of the partners contributing to greater access to healthcare knowledge and approaches that respond to the needs of people today.
This collaboration is therefore more than simply the launch of business partnerships. It also lays the foundation for knowledge exchange, the development of professional networks, and the creation of new opportunities in Regenerative Medicine on an ongoing basis.
THE FUTURE OF REGENERATIVE MEDICINE served as a platform for learning and exchanging perspectives among physicians, healthcare professionals, and industry partners, coming together to explore new directions for Regenerative Medicine.
INNOWAITA LAB believes that advancing the future of medicine requires collaboration among scientific knowledge, technology, experts, and partner organizations to create healthcare approaches that meet high standards and can be developed sustainably.
The launch of the collaboration between INNOWAITA LAB, Swiss Lab, and GENESENN, held in early August, therefore marked an important milestone in jointly advancing Regenerative Medicine while opening new opportunities for the development of medical knowledge and innovation in Thailand and internationally.
As the organizer of the event, INNOWAITA LAB was deeply honored and grateful for the participation of Dr. Masaaki Nagayama, physicians, healthcare professionals, partners, and distinguished guests who contributed to this important occasion and joined in opening new perspectives toward the future of medicine.
